Related topics: heart disease · drug · heart attack · cholesterol

New herbicide solution inspired by cholesterol medicine

Curtin University researchers have discovered a promising new herbicide target site in plants with the potential to provide new solutions for growers dealing with the increasing problem of herbicide resistance.

New nanoparticle drug combination for atherosclerosis developed

Physicochemical cargo-switching nanoparticles (CSNP) designed by KAIST can help significantly reduce cholesterol and macrophage foam cells in arteries, which are the two main triggers for atherosclerotic plaque and inflammation.

Team sequencing 1,000 fungal genomes

A 79-year-old collection of fungal cultures and the U.S. Forest Service's Northern Research Station are part of a team that will sequence 1,000 fungal genomes in the next 5 years.

Statin

The statins (or HMG-CoA reductase inhibitors) are a class of drugs that lower cholesterol levels in people with or at risk of cardiovascular disease.

They lower cholesterol by inhibiting the enzyme HMG-CoA reductase, which is the rate-limiting enzyme of the mevalonate pathway of cholesterol synthesis. Inhibition of this enzyme in the liver results in decreased cholesterol synthesis as well as increased synthesis of LDL receptors, resulting in an increased clearance of low-density lipoprotein (LDL) from the bloodstream. The first results can be seen after one week of use and the effect is maximal after four to six weeks.

This text uses material from Wikipedia, licensed under CC BY-SA